Apollo Cradle & Children’s Hospital set for significant expansion, plans 7-8 new centres in the next five years: Our Bureau, Bengaluru Tuesday, June 10, 2025, 17:10 Hrs [IST] Ap ...

Monash University to invest in a leading AI supercomputer to boost nation’s research capability: Our Bureau, Mumbai Tuesday, June 10, 2025, 17:20 Hrs [IST] Monash University wil ...

Since then, the NIMHANS team has been providing regular clinical services to these underserved patients. Nearly 2/3rds of these patients were out-of-treatment, and our team has provided services to ...

WuXi Biologics & Virogen Biotechnology establish commercial manufacturing partnership: Chengdu Tuesday, June 10, 2025, 17:00 Hrs [IST] WuXi Biologics, a leading global contract re ...

Sanofi presents positive results from DISCOVER phase 4 study of Dupixent in atopic dermatitis patients with skin of colour at 2025 RAD conference: Paris Tuesday, June 10, 2025, 16 ...

Harrow acquires US commercial rights to Byqlovi 0.05% from Formosa Pharma: Nashville, Tennessee Tuesday, June 10, 2025, 14:00 Hrs [IST] Harrow, a leading North American eyecare ph ...

WuXi Biologics & VISEN Pharmaceuticals partner to manufacture lonapegsomatropin at Chengdu microbial manufacturing site: Chengdu Tuesday, June 10, 2025, 15:00 Hrs [IST] WuXi Biolo ...

Parexel completes CDSCO registration under the new G.S.R 581(E) regulation: Our Bureau, Bengaluru Tuesday, June 10, 2025, 14:15 Hrs [IST] Parexel, one of the world’s largest cli ...

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season: Paris Tuesday, June 10, 2025, 11:00 Hrs [IST] Sanofi is shipp ...

Everest Medicines presents positive results in preliminary analysis of phase 1b/2a trial of novel BTK inhibitor EVER001 at ERA 2025 Congress: Shanghai, China Tuesday, June 10, 202 ...

CII Telangana to hold ‘Pillars of Protection’ conference on pharma & chemical industries safety on June 25 at Hyderabad: Our Bureau, Bengaluru Tuesday, June 10, 2025, 09:00 Hr ...

Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...